130 related articles for article (PubMed ID: 25862020)
1. Identification of Novel Inflammatory Cytokines and Contribution of Keratinocyte-Derived Chemokine to Inflammation in Response to Vibrio vulnificus Infection in Mice.
Liu XF; Wu J; Wang MY; Chen YJ; Cao Y; Hu CJ
Inflammation; 2015 Oct; 38(5):1864-73. PubMed ID: 25862020
[TBL] [Abstract][Full Text] [Related]
2. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.
Wang MY; Liu XF; Xia J; Li Y; Geng JL; Hu CJ
Future Microbiol; 2017 Sep; 12():953-965. PubMed ID: 28816516
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
Chuang CC; Chuang YC; Chang WT; Chen CC; Hor LI; Huang AM; Choi PC; Wang CY; Tseng PC; Lin CF
BMC Immunol; 2010 Oct; 11():50. PubMed ID: 20939898
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
[TBL] [Abstract][Full Text] [Related]
5. Vibrio vulnificus infection induces the maturation and activation of dendritic cells with inflammatory Th17-polarizing ability.
Lee A; Lim HX; Kim MS; Cho D; Jang KK; Choi SH; Kim TS
Int J Mol Med; 2018 Jan; 41(1):531-540. PubMed ID: 29115398
[TBL] [Abstract][Full Text] [Related]
6. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo.
Qin K; Fu K; Liu J; Wu C; Wang Y; Zhou L
Microb Pathog; 2019 Dec; 137():103789. PubMed ID: 31605759
[TBL] [Abstract][Full Text] [Related]
7. Vibrio vulnificus MO6-24/O lipopolysaccharide stimulates superoxide anion, thromboxane B₂, matrix metalloproteinase-9, cytokine and chemokine release by rat brain microglia in vitro.
Mayer AM; Hall ML; Holland M; De Castro C; Molinaro A; Aldulescu M; Frenkel J; Ottenhoff L; Rowley D; Powell J
Mar Drugs; 2014 Mar; 12(4):1732-56. PubMed ID: 24675728
[TBL] [Abstract][Full Text] [Related]
8.
Lee A; Kim MS; Cho D; Jang KK; Choi SH; Kim TS
Front Immunol; 2018; 9():2095. PubMed ID: 30283443
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen augments pro-inflammatory cytokine release in a mouse model of Vibrio vulnificus infection.
Lee YJ; Chuang YC
Microbiol Immunol; 2010 Sep; 54(9):542-50. PubMed ID: 20840153
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera.
Shin SH; Shin DH; Ryu PY; Chung SS; Rhee JH
FEMS Immunol Med Microbiol; 2002 Jun; 33(2):133-8. PubMed ID: 12052568
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Gene Expression Profiles, Cytokines, and Bacterial Loads Relevant to Alcoholic Liver Disease Mice Infected With
Feng ZH; Li SQ; Zhang JX; Ni B; Bai XR; Xu JH; Liu ZB; Xin WW; Kang L; Gao S; Wang J; Li YW; Li JX; Yuan Y; Wang JL
Front Immunol; 2021; 12():695491. PubMed ID: 34489943
[TBL] [Abstract][Full Text] [Related]
12. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.
Manjavachi MN; Costa R; Quintão NL; Calixto JB
Neuropharmacology; 2014 Apr; 79():17-27. PubMed ID: 24184386
[TBL] [Abstract][Full Text] [Related]
13. Vibrio vulnificus induces mTOR activation and inflammatory responses in macrophages.
Xie DL; Zheng MM; Zheng Y; Gao H; Zhang J; Zhang T; Guo JC; Yang XF; Zhong XP; Lou YL
PLoS One; 2017; 12(7):e0181454. PubMed ID: 28719654
[TBL] [Abstract][Full Text] [Related]
14. Detection of Vibrio vulnificus cytolysin in V. vulnificus-infected mice.
Gray LD; Kreger AS
Toxicon; 1989; 27(4):439-64. PubMed ID: 2658204
[TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus.
Lee BC; Kim SH; Choi SH; Kim TS
Immunology; 2005 Aug; 115(4):506-15. PubMed ID: 16011519
[TBL] [Abstract][Full Text] [Related]
16. Role of TLR4 in the host response to Vibrio vulnificus, an emerging pathogen.
Stamm LV
FEMS Immunol Med Microbiol; 2010 Apr; 58(3):336-43. PubMed ID: 20059544
[TBL] [Abstract][Full Text] [Related]
17. Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in mice.
Pan CY; Lee SC; Rajanbabu V; Lin CH; Chen JY
Dev Comp Immunol; 2012 Jan; 36(1):166-73. PubMed ID: 21756935
[TBL] [Abstract][Full Text] [Related]
18. A recombinant metalloprotease antigen of Vibrio vulnificus elicits protective antibodies in a murine model.
Chen YC; Chang CC; Chang SY; Su JH
Lett Appl Microbiol; 2010 Feb; 50(2):168-72. PubMed ID: 20002577
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recombinant leukocidin domain of VvhA exotoxin of Vibrio vulnificus as an effective toxoid in mouse model.
Lohith GK; Kingston JJ; Singh AK; Murali HS; Batra HV
Immunol Lett; 2015 Sep; 167(1):47-53. PubMed ID: 26141623
[TBL] [Abstract][Full Text] [Related]
20. Effect of antimicrobial agents on the toll-like receptors and inflammatory cytokines in liver tissue of the alcohol-induced liver disease in rats with Vibrio vulnificus sepsis.
Lu ZQ; Li MF; Qiu QM; Liang H; Zhou TL; Hong GL; Wu B
Chin Med J (Engl); 2009 Aug; 122(16):1910-6. PubMed ID: 19781370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
